Cargando…

The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis

Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanipour, Soheil, Vali, Mouhebat, Gaffari-fam, Saber, Nikbakht, Hossein-Ali, Abdzadeh, Elham, Joukar, Farahnaz, Pourshams, Akram, Shafaghi, Afshin, Malakoutikhah, Mahdi, Arab-Zozani, Morteza, Salehiniya, Hamid, Mansour-Ghanaei, Fariborz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003639/
https://www.ncbi.nlm.nih.gov/pubmed/32038120
http://dx.doi.org/10.17179/excli2019-1842
_version_ 1783494571342168064
author Hassanipour, Soheil
Vali, Mouhebat
Gaffari-fam, Saber
Nikbakht, Hossein-Ali
Abdzadeh, Elham
Joukar, Farahnaz
Pourshams, Akram
Shafaghi, Afshin
Malakoutikhah, Mahdi
Arab-Zozani, Morteza
Salehiniya, Hamid
Mansour-Ghanaei, Fariborz
author_facet Hassanipour, Soheil
Vali, Mouhebat
Gaffari-fam, Saber
Nikbakht, Hossein-Ali
Abdzadeh, Elham
Joukar, Farahnaz
Pourshams, Akram
Shafaghi, Afshin
Malakoutikhah, Mahdi
Arab-Zozani, Morteza
Salehiniya, Hamid
Mansour-Ghanaei, Fariborz
author_sort Hassanipour, Soheil
collection PubMed
description Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of patients with LC in Asian countries. The methodology of the present study is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The researchers searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until July 1, 2018. We also searched Google Scholar for detecting grey literature. The Newcastle-Ottawa Quality Assessment Form was used to evaluate the quality of selected papers. A total of 1425 titles were retrieved. 63 studies met the inclusion criteria. Based on the random-effect model one-year, three-year and five-year survival rate of LC were 34.8 % (95 % CI; 30.3-39.3), 19 % (95 % CI ; 18.2-21.8) and 18.1 % (95 % CI ;16.1-20.1) respectively. According to the results of our study, the LC survival rate in Asian countries is relatively lower than in Europe and North America.
format Online
Article
Text
id pubmed-7003639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Leibniz Research Centre for Working Environment and Human Factors
record_format MEDLINE/PubMed
spelling pubmed-70036392020-02-09 The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis Hassanipour, Soheil Vali, Mouhebat Gaffari-fam, Saber Nikbakht, Hossein-Ali Abdzadeh, Elham Joukar, Farahnaz Pourshams, Akram Shafaghi, Afshin Malakoutikhah, Mahdi Arab-Zozani, Morteza Salehiniya, Hamid Mansour-Ghanaei, Fariborz EXCLI J Review Article Hepatocellular carcinoma or Liver cancer (LC) is the sixth most common cancer and the fourth cause of death worldwide in 2018. There has not been a comprehensive study on the survival rate of patients with LC in Asia yet. Therefore, the present study was conducted to evaluate the survival rate of patients with LC in Asian countries. The methodology of the present study is based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The researchers searched five international databases including Medline/PubMed, Scopus, Embase, Web of Knowledge and ProQuest until July 1, 2018. We also searched Google Scholar for detecting grey literature. The Newcastle-Ottawa Quality Assessment Form was used to evaluate the quality of selected papers. A total of 1425 titles were retrieved. 63 studies met the inclusion criteria. Based on the random-effect model one-year, three-year and five-year survival rate of LC were 34.8 % (95 % CI; 30.3-39.3), 19 % (95 % CI ; 18.2-21.8) and 18.1 % (95 % CI ;16.1-20.1) respectively. According to the results of our study, the LC survival rate in Asian countries is relatively lower than in Europe and North America. Leibniz Research Centre for Working Environment and Human Factors 2020-01-13 /pmc/articles/PMC7003639/ /pubmed/32038120 http://dx.doi.org/10.17179/excli2019-1842 Text en Copyright © 2020 Hassanipour et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Review Article
Hassanipour, Soheil
Vali, Mouhebat
Gaffari-fam, Saber
Nikbakht, Hossein-Ali
Abdzadeh, Elham
Joukar, Farahnaz
Pourshams, Akram
Shafaghi, Afshin
Malakoutikhah, Mahdi
Arab-Zozani, Morteza
Salehiniya, Hamid
Mansour-Ghanaei, Fariborz
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title_full The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title_fullStr The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title_full_unstemmed The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title_short The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis
title_sort survival rate of hepatocellular carcinoma in asian countries: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003639/
https://www.ncbi.nlm.nih.gov/pubmed/32038120
http://dx.doi.org/10.17179/excli2019-1842
work_keys_str_mv AT hassanipoursoheil thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT valimouhebat thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT gaffarifamsaber thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT nikbakhthosseinali thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT abdzadehelham thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT joukarfarahnaz thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT pourshamsakram thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT shafaghiafshin thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT malakoutikhahmahdi thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT arabzozanimorteza thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT salehiniyahamid thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT mansourghanaeifariborz thesurvivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT hassanipoursoheil survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT valimouhebat survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT gaffarifamsaber survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT nikbakhthosseinali survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT abdzadehelham survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT joukarfarahnaz survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT pourshamsakram survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT shafaghiafshin survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT malakoutikhahmahdi survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT arabzozanimorteza survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT salehiniyahamid survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis
AT mansourghanaeifariborz survivalrateofhepatocellularcarcinomainasiancountriesasystematicreviewandmetaanalysis